Voyager Therapeutics (VYGR) Return on Equity (2016 - 2025)
Historic Return on Equity for Voyager Therapeutics (VYGR) over the last 11 years, with Q3 2025 value amounting to 0.55%.
- Voyager Therapeutics' Return on Equity fell 6200.0% to 0.55% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.55%, marking a year-over-year decrease of 6200.0%. This contributed to the annual value of 0.24% for FY2024, which is 11400.0% down from last year.
- Latest data reveals that Voyager Therapeutics reported Return on Equity of 0.55% as of Q3 2025, which was down 6200.0% from 0.42% recorded in Q2 2025.
- Voyager Therapeutics' Return on Equity's 5-year high stood at 0.72% during Q1 2023, with a 5-year trough of 1.04% in Q3 2021.
- Over the past 5 years, Voyager Therapeutics' median Return on Equity value was 0.21% (recorded in 2024), while the average stood at 0.18%.
- Per our database at Business Quant, Voyager Therapeutics' Return on Equity plummeted by -13700bps in 2021 and then skyrocketed by 15300bps in 2023.
- Over the past 5 years, Voyager Therapeutics' Return on Equity (Quarter) stood at 0.81% in 2021, then increased by 18bps to 0.67% in 2022, then skyrocketed by 196bps to 0.64% in 2023, then plummeted by -132bps to 0.21% in 2024, then crashed by -165bps to 0.55% in 2025.
- Its Return on Equity was 0.55% in Q3 2025, compared to 0.42% in Q2 2025 and 0.3% in Q1 2025.